At meeting held on 06 July 2021
The Board of Genesys International Corporation at its meeting held on 06 July 2021 has approved issuance of up to 15 lakh 11% Unsecured Compulsorily Convertible Debentures (CCDs) to Florintree Innovation LLP on a preferential basis at face value of Rs.122 per CCD convertible into upto 15 lakh equity shares at the end of 12 months from the date of allotment in accordance with SEBI (ICDR) Regulations, 2018.The Board also approved issuance of up to 7,50,000 warrants to Elizabeth Mathew on a preferential basis at a price of Rs. 122 per warrant, each convertible into 1 (one) equity share of the face value of Rs. 5/- (Rs five only) each fully paid up at a premium of Rs. 117 per share within a period of 18 (eighteen) months from the date of allotment in accordance with SEBI (ICDR) Regulations, 2018
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
